B. Anliker, T. Abel, and S. Kneissl, Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors, Nature Methods, vol.14, issue.11, pp.929-964, 2010.
DOI : 10.1038/nprot.2006.450

C. Bonini, M. Grez, and C. Traversari, Safety of retroviral gene marking with a truncated NGF receptor, Nature Medicine, vol.9, issue.4, pp.367-376, 2003.
DOI : 10.1038/nm0403-367

M. Cavrois, D. Noronha, C. Greene, and W. C. , A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes, Nature Biotechnology, vol.20, issue.11, pp.1151-1155, 2002.
DOI : 10.1038/nbt745

M. Cavrois, J. Neidleman, M. Bigos, and W. C. Greene, Fluorescence Resonance Energy Transfer-Based HIV-1 Virion Fusion Assay, Methods Mol. Biol, vol.263, pp.333-377, 2004.
DOI : 10.1385/1-59259-773-4:333

S. Charrier, M. Ferrand, and M. Zerbato, Quantification of lentiviral vector copy numbers in individual hematopoietic colony-forming cells shows vector dose-dependent effects on the frequency and level of transduction, Gene Therapy, vol.506, issue.5, pp.479-87, 2011.
DOI : 10.1371/journal.pone.0006461

I. Christodoulopoulos and P. M. Cannon, Sequences in the Cytoplasmic Tail of the Gibbon Ape Leukemia Virus Envelope Protein That Prevent Its Incorporation into Lentivirus Vectors, Journal of Virology, vol.75, issue.9, pp.4129-4167, 2001.
DOI : 10.1128/JVI.75.9.4129-4138.2001

K. Cornetta and A. W. , Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapy, Journal of Virological Methods, vol.23, issue.2, pp.187-94, 1989.
DOI : 10.1016/0166-0934(89)90132-8

D. , C. J. Mansfield, S. G. Humeau, and L. M. , Lentiviral vectors in clinical trials: Current status, Curr. Opin. Mol. Ther, vol.11, pp.554-64, 2009.

H. E. Davis, M. Rosinski, J. R. Morgan, and Y. M. , Charged Polymers Modulate Retrovirus Transduction via Membrane Charge Neutralization and Virus Aggregation, Biophysical Journal, vol.86, issue.2, pp.1234-1276, 2004.
DOI : 10.1016/S0006-3495(04)74197-1

N. K. Duggal and M. Emerman, Evolutionary conflicts between viruses and restriction factors shape immunity, Nature Reviews Immunology, vol.457, issue.10, pp.687-95, 2012.
DOI : 10.1038/nri3295

D. Fenard, S. Genries, and D. Scherman, Infectivity enhancement of different HIV-1-based lentiviral pseudotypes in presence of the cationic amphipathic peptide LAH4-L1, Journal of Virological Methods, vol.189, issue.2, pp.375-383, 2013.
DOI : 10.1016/j.jviromet.2013.02.005
URL : https://hal.archives-ouvertes.fr/inserm-00800499

D. Fenard, L. Houzet, and E. Bernard, Uracil DNA Glycosylase 2 negatively regulates HIV-1 LTR transcription, Nucleic Acids Research, vol.37, issue.18, pp.6008-6026, 2009.
DOI : 10.1093/nar/gkp673
URL : https://hal.archives-ouvertes.fr/hal-00420505

D. Fenard, D. Ingrao, and A. Seye, Vectofusin-1, a New Viral Entry Enhancer, Strongly Promotes Lentiviral Transduction of Human Hematopoietic Stem Cells, Molecular Therapy - Nucleic Acids, vol.2, 2013.
DOI : 10.1038/mtna.2013.17

C. Frecha, C. Costa, and D. Negre, Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins, Blood, vol.112, issue.13, pp.4843-52, 2008.
DOI : 10.1182/blood-2008-05-155945

C. Frecha, C. Levy, and C. Costa, Measles Virus Glycoprotein-Pseudotyped Lentiviral Vector-Mediated Gene Transfer into Quiescent Lymphocytes Requires Binding to both SLAM and CD46 Entry Receptors, Journal of Virology, vol.85, issue.12, pp.5975-85, 2011.
DOI : 10.1128/JVI.00324-11

C. Frecha, J. Szecsi, F. L. Cosset, and E. Verhoeyen, Strategies for Targeting Lentiviral Vectors, Current Gene Therapy, vol.8, issue.6, pp.449-60, 2008.
DOI : 10.2174/156652308786848003

B. Giebel, D. Corbeil, and J. Beckmann, Segregation of lipid raft markers including CD133 in polarized human hematopoietic stem and progenitor cells, Blood, vol.104, issue.8, pp.2332-2340, 2004.
DOI : 10.1182/blood-2004-02-0511

R. S. Harris, J. F. Hultquist, and D. T. Evans, The Restriction Factors of Human Immunodeficiency Virus, Journal of Biological Chemistry, vol.287, issue.49, pp.40875-83, 2012.
DOI : 10.1074/jbc.R112.416925

Y. Horiuchi, M. Onodera, and Y. Miyagawa, Cells During Murine Leukemia Virus-Derived Retroviral Transduction with Recombinant Fibronectin for Stem Cell Gene Therapy, Human Gene Therapy, vol.20, issue.7, pp.777-83, 2009.
DOI : 10.1089/hum.2008.159

A. Kichler, A. J. Mason, A. Marquette, and B. Bechinger, Histidine-Rich Cationic Amphipathic Peptides for Plasmid DNA and siRNA Delivery, Methods Mol. Biol, vol.948, pp.85-103, 2013.
DOI : 10.1007/978-1-62703-140-0_7

E. Kondo, F. Mammano, E. A. Cohen, and G. H. , The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles, J. Virol, vol.69, pp.2759-64, 1995.

J. K. Lam, W. Liang, and Y. Lan, Effective endogenous gene silencing mediated by pH responsive peptides proceeds via multiple pathways, Journal of Controlled Release, vol.158, issue.2, pp.293-303, 2012.
DOI : 10.1016/j.jconrel.2011.11.024

A. Lau, R. Kanaar, S. P. Jackson, O. Connor, and M. J. , Suppression of retroviral infection by the RAD52 DNA repair protein, The EMBO Journal, vol.4, issue.16, pp.3421-3430, 2004.
DOI : 10.1093/nar/27.24.4679

A. G. Lloyd, S. Tateishi, and P. D. Bieniasz, Effect of DNA Repair Protein Rad18 on Viral Infection, PLoS Pathogens, vol.74, issue.5, p.40, 2006.
DOI : 1098-5514(2000)074[9868:MBTHIV]2.0.CO;2

A. J. Mason, A. Martinez, and C. Glaubitz, The antibiotic and DNA-transfecting peptide LAH4 selectively associates with, and disorders, anionic lipids in mixed membranes, The FASEB Journal, vol.20, pp.320-322, 2006.
DOI : 10.1096/fj.05-4293fje

O. W. Merten, S. Charrier, and N. Laroudie, Gene Therapy Application, Human Gene Therapy, vol.22, issue.3, pp.343-56, 2011.
DOI : 10.1089/hum.2010.060

L. Naldini, Ex vivo gene transfer and correction for cell-based therapies, Nature Reviews Genetics, vol.2, issue.5, pp.301-316, 2011.
DOI : 10.1038/nrg2985

W. Paxton, R. I. Connor, and L. N. , Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis, J. Virol, vol.67, pp.7229-7266, 1993.

G. Pernod, R. Fish, J. W. Liu, and K. E. , Increasing lentiviral vector titer using inhibitors of protein kinase R, Biotechniques, vol.36, pp.576-584, 2004.

K. E. Pollok and W. D. , Facilitation of retrovirus-mediated gene transfer into hematopoietic stem and progenitor cells and peripheral blood T-lymphocytes utilizing recombinant fibronectin fragments, Curr. Opin. Mol. Ther, vol.1, pp.595-604, 1999.

N. R. Roan, J. Munch, and N. Arhel, The Cationic Properties of SEVI Underlie Its Ability To Enhance Human Immunodeficiency Virus Infection, Journal of Virology, vol.83, issue.1, pp.73-80, 2009.
DOI : 10.1128/JVI.01366-08

T. Rudoll, K. Phillips, and S. W. Lee, High-efficiency retroviral vector mediated gene transfer into human peripheral blood CD4+ T lymphocytes, Gene Ther, vol.3, pp.695-705, 1996.

V. Sandrin, B. Boson, and P. Salmon, Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates, Blood, vol.100, issue.3, pp.823-855, 2002.
DOI : 10.1182/blood-2001-11-0042

F. R. Santoni-de-sio, P. Cascio, and A. Zingale, Proteasome activity restricts lentiviral gene transfer into hematopoietic stem cells and is down-regulated by cytokines that enhance transduction, Blood, vol.107, issue.11, pp.4257-65, 2006.
DOI : 10.1182/blood-2005-10-4047

F. R. Santoni-de-sio, A. Gritti, and P. Cascio, Lentiviral Vector Gene Transfer Is Limited by the Proteasome at Postentry Steps in Various Types of Stem Cells, Stem Cells, vol.127, issue.8, pp.2142-52, 2008.
DOI : 10.1634/stemcells.2007-0705

K. Toyoshima and P. K. Vogt, Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions, Virology, vol.38, issue.3, pp.414-440, 1969.
DOI : 10.1016/0042-6822(69)90154-8

P. K. Vogt, DEAE-dextran: Enhancement of cellular transformation induced by avian sarcoma viruses, Virology, vol.33, issue.1, pp.175-182, 1967.
DOI : 10.1016/0042-6822(67)90109-2

A. F. Weil, D. Ghosh, and Y. Zhou, Uracil DNA glycosylase initiates degradation of HIV-1 cDNA containing misincorporated dUTP and prevents viral integration, Proc. Natl. Acad. Sci, 2013.
DOI : 10.1073/pnas.1219702110

D. Wolf and S. P. Goff, Host Restriction Factors Blocking Retroviral Replication, Annual Review of Genetics, vol.42, issue.1, pp.143-63, 2008.
DOI : 10.1146/annurev.genet.42.110807.091704
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598625

M. Wurm, A. Schambach, and D. Lindemann, The influence of semen-derived enhancer of virus infection on the efficiency of retroviral gene transfer, The Journal of Gene Medicine, vol.364, pp.137-183, 2010.
DOI : 10.1002/jgm.1429

S. Yamazaki, A. Iwama, and Y. Morita, Cytokine Signaling, Lipid Raft Clustering, and HSC Hibernation, Annals of the New York Academy of Sciences, vol.75, issue.1, pp.54-63, 2007.
DOI : 10.1126/science.7624798

K. Yoder, A. Sarasin, and K. Kraemer, The DNA repair genes XPB and XPD defend cells from retroviral infection, Proceedings of the National Academy of Sciences, vol.103, issue.12, pp.4622-4629, 2006.
DOI : 10.1073/pnas.0509828103

T. Yokota, K. Oritani, and H. Mitsui, Growth-supporting activities of fibronectin on hematopoietic stem/progenitor cells in vitro and in vivo: structural requirement for fibronectin activities of CS1 and cell-binding domains, Blood, vol.91, pp.3263-72, 1998.

M. Yolamanova, C. Meier, and A. K. Shaytan, Peptide nanofibrils boost retroviral gene transfer and provide a rapid means for concentrating viruses, Nature Nanotechnology, vol.318, issue.2, pp.130-136, 2013.
DOI : 10.1038/nnano.2012.248

J. Zhang, E. Attar, and K. Cohen, Silencing p21Waf1/Cip1/Sdi1 expression increases gene transduction efficiency in primitive human hematopoietic cells, Gene Therapy, vol.65, issue.19, pp.1444-52, 2005.
DOI : 10.1128/JVI.76.21.10942-10950.2002

J. Zhang, D. T. Scadden, and C. C. , Primitive hematopoietic cells resist HIV-1 infection via p21Waf1/Cip1/Sdi1, Journal of Clinical Investigation, vol.117, issue.2, pp.473-81, 2007.
DOI : 10.1172/JCI28971DS1
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1783820